Skip to main content
. Author manuscript; available in PMC: 2014 Mar 1.
Published in final edited form as: Ann Epidemiol. 2013 Jan 10;23(3):106–111. doi: 10.1016/j.annepidem.2012.12.004

Figure 1.

Figure 1

Projected potential population impact of the risk factors on cystatin C-based eGFR in non-diabetics; estimates were adjusted for all risk factors, study, age, sex, race, income, alcohol use, and history of cardiovascular disease and heart failure